CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
151 hedge funds and large institutions have $198M invested in Clovis Oncology, Inc. in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
28% less call options, than puts
Call options by funds: $4.29M | Put options by funds: $5.93M
32% less capital invested
Capital invested by funds: $292M → $198M (-$94.2M)
Holders
151
Holding in Top 10
1
Calls
$4.29M
Puts
$5.93M
Top Buyers
| 1 | +$3.92M | |
| 2 | +$3.9M | |
| 3 | +$3.04M | |
| 4 |
Rafferty Asset Management
New York
|
+$1.68M |
| 5 |
Citigroup
New York
|
+$1.51M |
Top Sellers
| 1 | -$5.91M | |
| 2 | -$1.82M | |
| 3 | -$1.32M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$670K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$542K |